RSS Feeds
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
- Michael F. Sorrell, MD;
- Edward A. Belongia, MD;
- Jose Costa, MD;
- Ilana F. Gareen, PhD;
- Jean L. Grem, MD;
- John M. Inadomi, MD;
- Earl R. Kern, PhD;
- James A. McHugh, MD;
- Gloria M. Petersen, PhD;
- Michael F. Rein, MD;
- Doris B. Strader, MD; and
- Hartwell T. Trotter, MS*
- From the University of Nebraska Medical Center, Omaha, Nebraska; Marshfield Clinic Research Foundation, Marshfield, Wisconsin; Yale University School of Medicine, New Haven, Connecticut; Brown University, Providence, Rhode Island; University of California, San Francisco, and San Francisco General Hospital, San Francisco, California; The University of Alabama School of Medicine, Birmingham, Alabama; University of Washington School of Medicine and Swedish Physicians—Central Seattle Clinic, Seattle, Washington; Mayo Clinic, Rochester, Minnesota; University of Virginia, Charlottesville, Virginia; University of Vermont College of Medicine, Burlington, Vermont; and American Melanoma Foundation, San Diego, California.
-
Figure. Natural history of chronic hepatitis B virus infection.HBsAg = hepatitis B surface antigen.
